Name
OÜ Kärdla Apteek
Registry code
10284665
VAT number
EE100662474
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
13.10.1997 (27)
Financial year
01.01-31.12
Capital
3 603.00 €
Activity
68201 - Rental and operating of own or leased real estate 47731 - Dispensing chemist in specialised stores
1 185 037 €
35 837 €
3%
2 183 €
(estimate is approximate)
225 783 €
4
Submitted
No tax arrears
16%
9%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Marge Noorkõiv 21.01.1965 (59) | 9% - 315.00 EUR | - | - | |
Viivika Oss 23.05.1966 (58) | 9% - 315.00 EUR | - | - | |
Krista Luuk 06.06.1954 (70) | 51% - 1 839.00 EUR | Board member | Direct ownership | |
Maret Ilves 10.12.1957 (66) | 31% - 1 134.00 EUR | Board member | Direct ownership |
2019 10.06.2020 | 2020 27.05.2021 | 2021 17.05.2022 | 2022 24.05.2023 | 2023 29.05.2024 | |
---|---|---|---|---|---|
Total Revenue | 956 442 € | 1 059 363 € | 1 090 272 € | 1 070 706 € | 1 185 037 € |
Net profit (loss) for the period | 37 822 € | 58 554 € | 50 386 € | 38 933 € | 35 837 € |
Profit Margin | 4% | 6% | 5% | 4% | 3% |
Current Assets | 170 000 € | 236 785 € | 278 207 € | 261 677 € | 323 428 € |
Fixed Assets | 74 655 € | 71 252 € | 68 352 € | 65 571 € | 62 499 € |
Total Assets | 244 655 € | 308 037 € | 346 559 € | 327 248 € | 385 927 € |
Current Liabilities | 87 367 € | 120 470 € | 137 586 € | 108 322 € | 160 144 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 157 288 € | 187 567 € | 208 973 € | 218 926 € | 225 783 € |
Employees | 4 | 4 | 4 | 4 | 4 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 310 509.97 € | 21 364.91 € | 15 586.76 € | 4 |
2023 Q4 | 299 030.6 € | 19 617.93 € | 12 215.56 € | 4 |
2023 Q3 | 280 368.62 € | 23 644.81 € | 15 831.39 € | 4 |
2023 Q2 | 314 110.3 € | 19 066.5 € | 14 171.16 € | 4 |
2023 Q1 | 283 840.44 € | 18 679.66 € | 13 331.94 € | 4 |
2022 Q4 | 261 066.37 € | 18 446.18 € | 11 457.5 € | 4 |
2022 Q3 | 279 154.54 € | 22 248.89 € | 14 414.12 € | 4 |
2022 Q2 | 267 346.5 € | 16 817.7 € | 12 746.06 € | 4 |
2022 Q1 | 271 300.46 € | 18 491.45 € | 13 228.21 € | 4 |
2021 Q4 | 286 728.01 € | 18 353.99 € | 10 846.26 € | 4 |
2021 Q3 | 270 496.29 € | 21 014.37 € | 13 571.39 € | 4 |
2021 Q2 | 253 694.59 € | 16 623.68 € | 11 876.24 € | 4 |
2021 Q1 | 264 228.31 € | 17 388.99 € | 12 389.28 € | 4 |
2020 Q4 | 269 935.12 € | 18 657.15 € | 9 662.02 € | 4 |
2020 Q3 | 263 980.71 € | 18 577.42 € | 12 049.69 € | 4 |
2020 Q2 | 270 271.91 € | 16 272.77 € | 9 705.4 € | 4 |
2020 Q1 | 252 689.53 € | 12 448.41 € | 9 755.41 € | 4 |